Novel Serum Biomarkers Detected by Protein Array in Polycystic Ovary Syndrome with Low Progesterone Level | Zendy

Qin Zheng | Zendy; Feifei Zhou | Zendy; Xinyuan Cui | Zendy; Mulin Liu | Zendy; LI Yu-lin | Zendy; Shuai Liu | Zendy; Jichun Tan | Zendy; Qiu Yan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Novel Serum Biomarkers Detected by Protein Array in Polycystic Ovary Syndrome with Low Progesterone Level

Author(s) -

Qin Zheng,

Feifei Zhou,

Xinyuan Cui,

Mulin Liu,

LI Yu-lin,

Shuai Liu,

Jichun Tan,

Qiu Yan

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000489619

Subject(s) - polycystic ovary , western blot , anovulation , endocrinology , biology , medicine , downregulation and upregulation , infertility , blot , ovary , insulin , insulin resistance , pregnancy , gene , biochemistry , genetics

Polycystic ovary syndrome (PCOS), characterized by female infertility and metabolic abnormalities, is one of the most common endocrine disorders. The etiology of PCOS remains unknown. The comprehensive analysis of protein alterations in PCOS patients is meaningful for identifying diagnostic biomarkers of PCOS. Here, we explored the clinical value of serum proteins as novel biomarkers to detect PCOS with low progesterone level.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research